Jan. 29, 2026
Combat Casualty Care Technology Receives FDA Breakthrough Designation for the “AI-GUIDE”
JOINT BASE SAN ANTONIO-LACKLAND, Texas —
The Defense Health Agency marked a major milestone in battlefield medicine after the FDA granted Breakthrough Device Designation to the AI-GUIDE system, an AI-enabled robotic ultrasound device developed by MIT Lincoln Laboratory. Designed for austere and high-stress environments, AI-GUIDE helps frontline medical personnel rapidly and accurately establish vascular access, a critical capability in treating noncompressible torso hemorrhage, a leading cause of preventable combat deaths. The achievement reflects close collaboration among the DHA, 59th Medical Wing, 959th Medical Group, Brooke Army Medical Center, and MIT researchers to accelerate life-saving innovation for warfighters.